JUN 30, 2015 12:48 PM PDT

Vanderbilt Chemists Organize a Microbial Fight Club

WRITTEN BY: Kerry Evans
Bacteria produce a medley of secondary metabolites in response to their environment. Often, these metabolites are used to fend off rival microorganisms, making them ideal antibacterial and anticancer drug candidates. However, many of these metabolites are not produced when bacteria are grown in monoculture. A group of Vanderbilt University chemists solved this problem by organizing a microbial fight club.

Brian Bachmann, Associate Professor of Chemistry, and John McLean, Stevenson Professor of Chemistry, describe their unique approach to drug discovery in the journal ACS Chemical Biology (ACS Chem Biol. 2015 Jun 17). The group co-cultured the soil-dwelling bacterium Nocardiopsis with Escherichia coli, Bacillus subtilis, Rhodococcus wratislaviensis, and Tsukamurella pulmonis.

Vanderbilt University chemists designed a bacterial fight club to discover new drugs.
They looked for secondary metabolites in the co-culture media using ion mobility-mass spectrometry, a technique that sorts molecules based on their size to weight ratio. This approach identified upwards of 2,500 unique molecules from each co-culture. In each case, more metabolites were found in the co-culture than in either individual culture combined, suggesting that unique metabolites were produced when different species interacted.

To identify metabolites that were similar in structure to known antibiotics and anticancer drugs, the researchers developed a "self-organizing metabolomics map". This approach identified a unique metabolite from the Nocardiopsis/Rhodococcus co-culture, a macrolactam type polyketide now named "ciromicin".

This isn't the Bachmann Lab's only creative approach to drug discovery. In collaboration with Hazel Barton, Professor of Microbiology and Geology at the University of Akron, Bachmann looked for novel antibiotics made by cave-dwelling bacteria. One sample from Lechuguilla Cave in New Mexico contained 38 antibiotic compounds, an impressive figure when you consider there are fewer than 100 known antibiotics.

Sources: ACS Chemical Biology, Science Daily, BBC
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
MAR 01, 2021
Cell & Molecular Biology
Sulfur May've Been Essential to the Evolution of Multicellular Life
MAR 01, 2021
Sulfur May've Been Essential to the Evolution of Multicellular Life
We've heard a lot about how important carbon and water are to life, but sulfur? Researchers think that sulfur may have a ...
MAR 03, 2021
Microbiology
Study May Explain Higher Flu Risk in Adults That Were Premature Babies
MAR 03, 2021
Study May Explain Higher Flu Risk in Adults That Were Premature Babies
Medical treatments for the care of premature babies have allowed many individuals to get through that challenge and lead ...
APR 04, 2021
Cell & Molecular Biology
Human Malaria Trial Creates More Questions
APR 04, 2021
Human Malaria Trial Creates More Questions
Malaria is a major health problem in many parts of the world; nearly half a million people die from malaria, and another ...
APR 09, 2021
Microbiology
A Neurological Disorder Sometimes Seen After Vaccinations
APR 09, 2021
A Neurological Disorder Sometimes Seen After Vaccinations
Functional neurological disorder (FND) is a real neuropsychiatric disorder that some people have after medical procedure ...
MAY 04, 2021
Immunology
One Vaccine to Rule Them All
MAY 04, 2021
One Vaccine to Rule Them All
There are currently five variants of concern in the U.S., genetically distinct forms of the COVID-causing coronavirus th ...
MAY 04, 2021
Cell & Molecular Biology
A Potential Weakness in SARS-CoV-2 is Caught on Video
MAY 04, 2021
A Potential Weakness in SARS-CoV-2 is Caught on Video
You can see the spike protein of the virus in action in this video.
Loading Comments...